Published in Gut on June 01, 2000
Transabdominal modified devascularization procedure with or without esophageal stapler transection--an operation adequate for effective control of a variceal bleed. Is esophageal stapler transection necessary? World J Surg (2006) 1.42
The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol (2007) 1.23
Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage. World J Gastroenterol (2013) 1.05
Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol (2013) 1.03
Non-alcoholic fatty liver disease: a practical approach to treatment. Frontline Gastroenterol (2014) 1.01
Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates. World J Gastroenterol (2010) 0.97
Complications of gastrointestinal endoscopy. Gut (2007) 0.93
Human thrombin for the treatment of gastric and ectopic varices. World J Gastroenterol (2012) 0.93
Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg (2009) 0.93
Canadian credentialing guidelines for esophagogastroduodenoscopy. Can J Gastroenterol (2008) 0.92
The first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: pilot study. Saudi J Gastroenterol (2013) 0.91
An assessment of endoscopic and concomitant management of acute variceal bleeding at a tertiary care centre. Can J Gastroenterol (2007) 0.91
Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data. Clin Mol Hepatol (2013) 0.87
Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring. Eur Radiol (2009) 0.87
Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients. World J Gastroenterol (2008) 0.83
Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication? Ther Clin Risk Manag (2008) 0.82
Prevention and management of bacterial infections in cirrhosis. Int J Hepatol (2011) 0.82
Update of endoscopy in liver disease: more than just treating varices. World J Gastroenterol (2012) 0.81
Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance. Ther Adv Chronic Dis (2013) 0.80
Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis. J Clin Biochem Nutr (2014) 0.80
Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding. World J Gastroenterol (2014) 0.80
Historical overview and review of current day treatment in the management of acute variceal haemorrhage. World J Gastroenterol (2014) 0.79
Delayed onset pulmonary glue emboli in a ventilated patient: a rare complication following endoscopic cyanoacrylate injection for gastric variceal haemorrhage. BMJ Case Rep (2014) 0.79
Gastric varices: Classification, endoscopic and ultrasonographic management. J Res Med Sci (2015) 0.78
Differences in bleeding behavior after endoscopic band ligation: a retrospective analysis. BMC Gastroenterol (2010) 0.77
Long-term results of the paraesophagogastric devascularization with or without esophageal transection: which is more suitable for variceal bleeding? World J Surg (2014) 0.77
Management of variceal haemorrhage in cirrhotic patients. Gut (2001) 0.76
Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging. Semin Intervent Radiol (2011) 0.76
Republished: Non-alcoholic fatty liver disease: a practical approach to treatment. Postgrad Med J (2015) 0.76
Anatomy and classification of gastrorenal and gastrocaval shunts. Semin Intervent Radiol (2011) 0.76
Management of acute variceal bleeding using hemostatic powder. United European Gastroenterol J (2015) 0.75
Duodenal variceal bleed: an unusual cause of upper gastrointestinal bleed and a difficult diagnosis to make. BMJ Case Rep (2017) 0.75
Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. Ann Gastroenterol (2013) 0.75
Endoscopy management algorithms: role of cyanoacrylate glue injection and self-expanding metal stents in acute variceal haemorrhage. Frontline Gastroenterol (2014) 0.75
Inferolateral ST-segment elevation associated with a gastric variceal bleed and the use of a Minnesota tube. BMJ Case Rep (2014) 0.75
Transjugular intrahepatic portosystemic shunt (TIPS) versus laparoscopic splenectomy (LS) plus preoperative endoscopic varices ligation (EVL) in the treatment of recurrent variceal bleeding. Surg Endosc (2013) 0.75
Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding. World J Gastroenterol (2017) 0.75
Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis-the first 24 h. Frontline Gastroenterol (2014) 0.75
EVS vs TIPS shunt for gastric variceal bleeding in patients with cirrhosis: A meta-analysis. World J Gastrointest Pharmacol Ther (2014) 0.75
Long-term outcomes of endoscopic variceal ligation to prevent rebleeding in children with esophageal varices. J Korean Med Sci (2013) 0.75
Efficacy and safety of balloon-occluded retrograde transvenous obliteration for gastric fundal varices in children. Pediatr Surg Int (2008) 0.75
Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1. Dig Dis Sci (2007) 0.75
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet (1993) 8.54
North of England evidence based guidelines development project: methods of guideline development. BMJ (1996) 5.12
Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology (1992) 4.22
Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet (1990) 3.37
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
Developing clinically valid practice guidelines. J Eval Clin Pract (1995) 3.26
The treatment of portal hypertension: a meta-analytic review. Hepatology (1995) 3.11
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99
Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol (1996) 2.81
Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.69
Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc (1981) 2.62
A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg (1971) 2.46
A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology (1989) 2.40
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med (1992) 2.31
Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet (1982) 2.30
A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med (1969) 2.19
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology (1999) 2.18
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.17
Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med (1993) 2.16
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology (1985) 2.09
A controlled study of the therapeutic portacaval shunt. Gastroenterology (1974) 2.05
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology (1990) 2.02
Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology (1980) 2.02
Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet (1983) 2.01
Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc (1986) 1.99
Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med (1999) 1.98
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet (1993) 1.82
Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology (1985) 1.80
Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med (1990) 1.75
A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. Am J Surg (1968) 1.72
Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology (1992) 1.71
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67
Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology (1996) 1.64
Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR Am J Roentgenol (1996) 1.63
Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology (1997) 1.63
A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J (Clin Res Ed) (1985) 1.62
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology (1984) 1.56
PROPHYLACTIC PORTACAVAL ANASTOMOSIS IN CIRRHOTIC PATIENTS WITH ESOPHAGEAL VARICES: A PROGRESS REPORT OF A CONTINUING STUDY. N Engl J Med (1965) 1.55
Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy (1995) 1.55
The natural history of esophageal varices; a study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding. Am J Med (1959) 1.53
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc (1997) 1.52
A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol (1996) 1.51
The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg (1985) 1.50
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet (1997) 1.47
Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology (1988) 1.45
Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg (1979) 1.41
Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci (1988) 1.40
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg (1996) 1.37
Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology (1984) 1.36
Endoscopic sclerotherapy versus portacaval shunt in patient with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up. N Engl J Med (1987) 1.35
Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology (1985) 1.35
Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med (1987) 1.34
N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy. Endoscopy (1987) 1.31
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology (1999) 1.29
Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology (1975) 1.28
Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology (1996) 1.28
Comparison of distal and proximal splenorenal shunts: a randomized prospective trial. Ann Surg (1981) 1.27
Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology (1981) 1.25
Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology (1981) 1.25
Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study. Lancet (1985) 1.25
Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology (1995) 1.24
Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology (1985) 1.23
Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1994) 1.23
Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology (1987) 1.22
Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology (1995) 1.21
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology (1997) 1.20
Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg (1982) 1.19
Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology (1996) 1.19
A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology (1985) 1.19
Endoscopic sclerotherapy v. conservative management of bleeding oesophageal varices. A 5-year prospective controlled trial of emergency and long-term treatment. Acta Chir Scand (1985) 1.18
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology (1998) 1.18
Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology (1981) 1.15
A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol (1992) 1.15
Endoscopic esophageal varix ligation: preliminary clinical experience. Gastrointest Endosc (1988) 1.14
Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial. Ann Surg (1987) 1.13
Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology (1991) 1.13
Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology (1989) 1.13
Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg (1986) 1.13
A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology (1986) 1.11
Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology (1992) 1.10
A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med (1989) 1.10
Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology (1996) 1.08
Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology (1986) 1.08
A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology (1995) 1.07
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology (1999) 1.07
Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis (1986) 1.07
Developing consensus in portal hypertension. J Hepatol (1996) 1.05
Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med (1996) 1.05
Endoscopic ligation of esophageal varices compared with injection sclerotherapy: a prospective randomized trial. Gastrointest Endosc (1993) 1.04
[Natural history of esophageal varices in cirrhosis (from origin to rupture)]. Gastroenterol Clin Biol (1988) 1.04
Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. Scand J Gastroenterol (1989) 1.04
Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology (1985) 1.02
Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg (1994) 1.02
Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology (1988) 1.01
The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol (1998) 1.01
Should methionine be added to every paracetamol tablet? BMJ (1997) 3.33
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Hepatotoxicity of herbal remedies. BMJ (1989) 2.37
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet (1999) 1.89
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2010) 1.87
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol (1995) 1.84
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
Hepatic encephalopathy and ascites. Lancet (1997) 1.57
Randomised clinical study: comparison of acceptability, patient tolerance, cardiac stress and endoscopic views in transnasal and transoral endoscopy under local anaesthetic. Aliment Pharmacol Ther (2014) 1.54
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther (2003) 1.49
TIPSS 10 years on. Gut (2000) 1.48
Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol (1997) 1.48
The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation (2000) 1.47
Hepatotoxicity of sodium stibogluconate in leishmaniasis. Lancet (1993) 1.42
Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology (1995) 1.40
The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther (2012) 1.40
The hands in alcoholic liver disease. Am J Gastroenterol (1991) 1.39
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther (2008) 1.38
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut (2000) 1.20
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology (2000) 1.14
Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol (1996) 1.12
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther (2012) 1.10
Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut (1997) 1.09
The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut (2008) 1.08
Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. Clin Radiol (1992) 1.07
Review article: the current management of acute liver failure. Aliment Pharmacol Ther (2009) 1.06
Screening for hepatocellular carcinoma. Eur J Gastroenterol Hepatol (1996) 1.04
Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res (1998) 1.04
The influence of captopril, the nitrates and propranolol on apparent liver blood flow. Br J Clin Pharmacol (1985) 1.04
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut (2003) 1.04
Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. QJM (1998) 1.03
Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis. Hepatology (2001) 1.01
Age, anemia, and obesity-associated oxygen desaturation during upper gastrointestinal endoscopy. Gastrointest Endosc (1993) 1.01
Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl (2000) 1.01
Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl (2001) 1.01
A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther (1997) 1.00
Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther (2001) 1.00
Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther (2002) 1.00
Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis (1988) 1.00
Evidence of hydrogen ion secretion from the human gall bladder in vitro. Gut (1992) 0.99
Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'. QJM (2002) 0.99
Transjugular intrahepatic portosystemic stent-shunt (TIPSS): long-term follow-up. QJM (1994) 0.98
Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology (1989) 0.98
Review article: the management of acute liver failure. Aliment Pharmacol Ther (1998) 0.97
Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet (1995) 0.96
Review article: recent advances in the management of bleeding gastric varices. Aliment Pharmacol Ther (2006) 0.96
Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment Pharmacol Ther (2000) 0.95
Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors. J Infect Dis (1998) 0.95
Association between chronic hepatitis C infection and hepatocellular carcinoma. Lancet (1995) 0.94
Review article: quantitative tests of liver function. Aliment Pharmacol Ther (1995) 0.94
A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Qual Life Res (2000) 0.94
The simulated microgravity environment maintains key metabolic functions and promotes aggregation of primary porcine hepatocytes. Biochim Biophys Acta (2001) 0.94
The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol (1998) 0.93
Serum hyaluronan--a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol (2000) 0.93
A passive haemagglutination (TRC) inhibitor in thyrotoxic serum. Clin Endocrinol (Oxf) (1979) 0.93
Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy. Aliment Pharmacol Ther (2014) 0.92
The liver in typhoid fever: always affected, not just a complication. Am J Gastroenterol (1991) 0.92
The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. Clin Radiol (2011) 0.92
Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet (1991) 0.91
Plasma glutathione S-transferase measurements in patients with alcoholic cirrhosis. Clin Chim Acta (1987) 0.91
Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis. J Hepatol (1999) 0.90
Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograft. FASEB J (1998) 0.90
Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland. Lancet (2001) 0.89
Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites. Gut (2005) 0.89
Glutathione S-transferase in human bile. Clin Chim Acta (1989) 0.89
Autonomic function in cirrhosis assessed by cardiovascular reflex tests and 24-hour heart rate variability. Am J Gastroenterol (1994) 0.88
Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response. Blood (1996) 0.88
Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1995) 0.88
Glutathione S-transferases in alcoholic liver disease. Gut (1990) 0.87
Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae. J Hepatol (1996) 0.87
The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man. Am J Gastroenterol (1999) 0.87
Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices. Hepatology (1989) 0.86
A new method for semi-automated quantitation of E-rosettes using a particle size analyser (Coulter Channelyzer). J Immunol Methods (1979) 0.86
The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. J Hepatol (1995) 0.86
In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis. Pharmacol Ther (1997) 0.86
Liver biopsy bleeding time: an unpredictable event. J Gastroenterol Hepatol (1994) 0.86
Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther (2010) 0.86
The effect of strenuous physical exercise on circulating blood lymphocytes and serum cortisol levels. J Clin Lab Immunol (1981) 0.85
The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection. Liver Transpl Surg (1998) 0.85
EUS-assisted thrombin injection for ectopic bleeding varices--a case report and review of the literature. QJM (2011) 0.85
Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma. Eur J Gastroenterol Hepatol (2000) 0.85
Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. J Hepatol (1999) 0.85
Laparoscopy and histology in the diagnosis of chronic liver disease. QJM (1995) 0.85
Comparison of the Glasgow alcoholic hepatitis score and the ABIC score for the assessment of alcoholic hepatitis. Am J Gastroenterol (2010) 0.85
Transjugular intrahepatic portasystemic stent-shunt in the treatment of variceal haemorrhage. Br J Surg (1995) 0.85
Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis. J Hepatol (1996) 0.85
The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland. Clin Exp Dermatol (1996) 0.84
Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transpl Surg (1997) 0.84
Selective alteration of agonist-mediated contraction in hepatic arteries isolated from patients with cirrhosis. Gastroenterology (2000) 0.84
Alcoholic hepatitis: from pathogenesis to treatment. Curr Med Res Opin (2005) 0.84